SARI DAWN EDELMAN DO NPI 1528253051

NPI Information

  • NPI: 1528253051
  • Provider Name: SARI DAWN EDELMAN, DO
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1831 N BELCHER RD STE D2
    CLEARWATER, FL
    ZIP 33765
  • Phone: (727) 734-6631

Map and Directions

Get Directions

NPI Details

Sari Dawn Edelman, DO is a rheumatology internal medicine in Clearwater, FL with 22 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Sari Dawn Edelman, DO NPI is 1528253051. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Graduation Year:2003

The provider's business location address is:

1831 N BELCHER RD STE D2
CLEARWATER, FL
ZIP 33765-450
Phone: (727) 734-6631
Fax: (727) 551-5837

The NPI 1528253051 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • X-ray of wrist, minimum of 3 views (HCPCS:73110)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • X-ray lower and sacral spine, minimum of 6 views (HCPCS:72114)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • X-ray of ankle, minimum of 3 views (HCPCS:73610)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Mri scan of arm before and after contrast (HCPCS:73220)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Mri scan of arm joint before and after contrast (HCPCS:73223)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • X-ray of both knees while standing (HCPCS:73565)
  • X-ray of upper spine, 6 or more views (HCPCS:72052)
  • Mri scan of lower spinal canal without contrast (HCPCS:72148)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • X-ray of both hips, 2 views (HCPCS:73521)
  • X-ray of middle spine, 2 views (HCPCS:72070)
  • Mri scan of arm joint without contrast (HCPCS:73221)
  • X-ray of joint between lower spine and hip bone, 3 or more views (HCPCS:72202)

The enumeration date for this NPI number is 9/7/2007 and was last updated on 6/11/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyOS17624FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.